EBOV entry-IN-1

• Description:

  EBOV entry-IN-1 (compound Hu7) is an EBOV entry inhibitor with an IC50 of 1.50 μM[1].

• UNSPSC:

  12352005

• Target:

  Filovirus

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Smiles:

  ClC(C=C1)=CC=C1CNCCCN2CC3=CC=CC=C3C[C@H]2C(NC)=O

• Molecular Formula:

  C21H26ClN3O

• Molecular Weight:

  371.90

• References & Citations:

  [1]Lin J, et al. Discovery of novel Ebola entry inhibitors with 1,2,3,4-tetrahydroisoquinoline-3-carboxamide based on (3S,4aS,8aS) -2- (3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold. Bioorg Med Chem Lett. 2025 Aug 1;123:130230.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported